Several studies have indicated that NR3C2 can be a tumor suppressor gene in cancers such as colorectal, pancreatic, and cervical cancers (Fabio et al., 2007; Huang et al., 2011; Pesson et al., 2014; Yang et al., 2016). This evidence concerns the gene NR3C2 and cancer.